Peter Buhl Jensen, M.d. Dmsc
Oncology
2x Oncology
United States of America
Biography
Dr. Buhl Jensen is MD, DMSc and professor in clinical oncology and is CEO of Oncology Venture and Medical Prognosis Institute. Dr. Buhl Jensen has a strong combination of commercial experience and expertise in the field of oncology.
Research Interest
pharmaceutical drug Belinostat